Scott Boyer

Scott Boyer is currently the Chief Executive Officer at Chemotargets SL since October 2020. Scott also serves as the Chief Scientific Advisor at Klaria Pharma AB since January 2015. With previous experience at companies like Swetox and AstraZeneca, Scott has held various high-level positions in the fields of Computational Toxicology and Molecular Toxicology. Additionally, Scott has a strong educational background with a Ph.D. in Molecular Toxicology from the University of Colorado Boulder.